Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Prostate Specific Antigen antibody (AA 18-261)

The Mouse Monoclonal anti-Prostate Specific Antigen antibody has been validated for WB and Neut. It is suitable to detect Prostate Specific Antigen in samples from Human.
Catalog No. ABIN1983317

Quick Overview for Prostate Specific Antigen antibody (AA 18-261) (ABIN1983317)

Target

See all Prostate Specific Antigen (PSA) Antibodies
Prostate Specific Antigen (PSA)

Reactivity

  • 237
  • 14
  • 13
  • 6
  • 1
  • 1
  • 1
Human

Host

  • 143
  • 93
  • 4
  • 3
  • 2
Mouse

Clonality

  • 170
  • 76
Monoclonal

Conjugate

  • 141
  • 16
  • 11
  • 8
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
This Prostate Specific Antigen antibody is un-conjugated

Application

  • 123
  • 82
  • 69
  • 62
  • 33
  • 25
  • 24
  • 24
  • 24
  • 12
  • 12
  • 10
  • 7
  • 5
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Neutralization (Neut)

Clone

MM0430-5F28
  • Binding Specificity

    • 8
    • 8
    • 7
    • 6
    • 6
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 18-261

    Characteristics

    Mouse anti human Kallikrein 3

    Immunogen

    AA 18-261

    Isotype

    IgG2
  • Application Notes

    Optimal dilutions should be determined by each laboratory for each application.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    200 µL of PBS, pH 7.4

    Concentration

    500 µg/mL

    Buffer

    Lyophilized from a solution containing PBS, pH 7.4

    Storage

    -20 °C
  • Target

    Prostate Specific Antigen (PSA)

    Alternative Name

    Kallikrein 3

    UniProt

    P07288

    Pathways

    Complement System
You are here:
Chat with us!